Inclusion of SRRM4-regulated exons is decreased in tumors and cancer cell lines. by Sarah A. Head (6066398)

“…Red points are exons with PSI decreasing by at least 5% in at least 1 tumor type. …”

Shadow prices of metabolites that decrease flux through reactions from Random Forest. by Deborah A. Powers (15361394)

“…<p>For each objective function (OF) listed in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1011076#pcbi.1011076.g003" target="_blank">Fig 3A</a>, the metabolites categorized as decreasing and with a shadow price < -5 are shown.…”

Dcp1a protein levels are decreased by KapB expression and Torin treatment. by Carolyn-Ann Robinson (13297009)

SLAMF6 knock down or knock out leads to a decrease in TCR activation. by Matthew A. Dragovich (6843362)

Propagation of an action potential through ephaptic coupling is achieved for a decreased extracellular conductivity. by Karoline Horgmo Jæger (6785450)

Healthspan decreases in response to cell-associated factor LPS in a dose-dependent manner. by Gabriel M. Moore (8566113)

An enhanced clot growth rate before in vitro fertilization decreases the probability of pregnancy by A. N. Balandina (6729380)

Expression of a phosphomimetic Hcm1 mutant decreases fitness in LiCl stress. by Michelle M. Conti (13514386)

Reversion to susceptibility was consistent with decreasing relative <i>vanA</i> copy number. by Samuel E. Blechman (19506884)

<i>clec-4</i> mutants show a decreased early offspring production. by Barbara Pees (3313560)

Decrease of Sun4 protein level upon <i>eIF2A</i> overexpression requires the presence of Ssd1. by Laura Meyer (4033793)

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

Growth on stiff substrate results in mild lifespan extension but a decrease in organismal health. by Maria Oorloff (19658113)

LOH resulting in 189R/R produces a strong decrease in drug susceptibility. by Pétra Vande Zande (17628246)

Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. by Kaley M. Wilburn (12060476)

When there is information, (A) V challenge less and (B) R resist the same. by Aron Szekely (8286549)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

Decreased Th2 immunity with ID93+GLA-LSQ compared to ID93 alone. by Susan L. Baldwin (10291449)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Comparison of human measures of motor learning across the Start phase (5 first games) and the Middle phase (5 middle games) of <i>Auto Orbit</i>. by Pierre Giovanni Gianferrara (11553077)